Physical Activity During Social Isolation

December 29, 2020 updated by: Saliha Gürdal Karakelle, Istanbul University-Cerrahpasa

What Are the Factors That Affect the Physical Activity Levels of Young Adults During Social Isolation Due to Coronavirus?

The aim of the study is to evaluate the physical activity level and the factors affecting physical activity among young adults who are socially isolated due to coronavirus.

Study Overview

Status

Completed

Conditions

Study Type

Observational

Enrollment (Actual)

1206

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • İstanbul, Turkey, 34500
        • Ozge Ertan

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 50 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Probability Sample

Study Population

Young Adults from Community Sample

Description

Inclusion Criteria:

  • Being between the ages of 18-50
  • Being volunteer

Exclusion Criteria:

  • Being unable to communicate in Turkish
  • Not knowing read and write in Turkish

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Exercise Habit and Factors Affecting Exercise Attendance
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
It was created by the researchers due to the fact that the existing surveys could not meet the pandemic period. It will be questioned whether the participants had exercise habits in the times before the pandemic. Possible reasons will be questioned according to the positive and negative answers. The answers of the questions are yes / no and they will not be scored. Frequency evaluation will be made according to the results obtained.
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
International Physical Activity Questionnaire - Short Form (IPAQ-SF)
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
IPAQ-SF provides information on walking, moderate and vigorous activities and time spent sitting, within a week. There are two forms of output from scoring the IPAQ. Results can be reported in categories (low activity levels, moderate activity levels or high activity levels) or as a continuous variable (MET minutes a week). MET minutes represent the amount of energy expended carrying out physical activity.
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
Exercise Benefits/Barriers Scale
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
It was developed in response to a need for an instrument to determine perceptions of individuals concerning the benefits and barriers to participating in exercise. The scale, which is a 4-point Likert type, has 4 responses from 4 (strongly agree) to 1 (strongly disagree). The total score of the scale varies between 43-172. Higher scores mean that knowing the benefits of exercise and no barrier to exercise.
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
The Pittsburgh Sleep Quality Index
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
The Pittsburgh Sleep Quality Index (PSQI) is a self-report questionnaire that assesses sleep quality over a 1-month time interval. It consists of 24 questions, 18 of which are included in the scoring. Each question is scored between 0-3 and the highest total score is 21. The high total score indicates poor sleep quality.
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
The Hospital Anxiety and Depression Scale
Time Frame: The assessment will be made once at baseline, data collection will be completed up to 6 weeks.
A self-assessment scale has been developed and found to be a reliable instrument for detecting states of depression and anxiety. The questions of the scale, which is a 4-point Likert type, are scored between 0-3. The total score is obtained between 0-21. The high score indicates the presence of depression and anxiety.
The assessment will be made once at baseline, data collection will be completed up to 6 weeks.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: AYSE ZENGIN ALPOZGEN, PhD, Istanbul University-Cerrahpasa

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 1, 2020

Primary Completion (Actual)

May 31, 2020

Study Completion (Actual)

May 31, 2020

Study Registration Dates

First Submitted

April 3, 2020

First Submitted That Met QC Criteria

April 5, 2020

First Posted (Actual)

April 9, 2020

Study Record Updates

Last Update Posted (Actual)

December 30, 2020

Last Update Submitted That Met QC Criteria

December 29, 2020

Last Verified

December 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • 30042020-1

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Social Isolation

3
Subscribe